BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 4213015)

  • 1. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
    [No Abstract]   [Full Text] [Related]  

  • 2. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice.
    Scott MT
    J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the tumor-specific immune response by Corynebacterium parvum.
    Scott MT
    J Natl Cancer Inst; 1975 Jul; 55(1):65-72. PubMed ID: 808637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of cell-mediated tumour immunity by Corynebacterium parvum.
    Kirchner H; Glaser M; Herberman R
    Nature; 1975 Oct; 257(5525):396-8. PubMed ID: 170531
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of the antitumor action of Corynebacterium parvum by stress.
    Turney TH; Harmsen AG; Jarpe MA
    Physiol Behav; 1986; 37(4):555-8. PubMed ID: 3092254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the combination of Corynebacterium parvum and levamisole on murine tumors.
    Anaclerio A; Conti G; Moras ML; Barale C; Spreafico F
    Eur J Cancer (1965); 1977 Dec; 13(12):1451-53. PubMed ID: 413718
    [No Abstract]   [Full Text] [Related]  

  • 8. Corynebacterium parvum as an immunotherapeutic anticancer agent.
    Scott MT
    Semin Oncol; 1974 Dec; 1(4):367-78. PubMed ID: 4620441
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of macrophage activation by corynebacterium parvum. II. In vivo experiments.
    Bomford R; Christie GH
    Cell Immunol; 1975 May; 17(1):150-5. PubMed ID: 1079165
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemical and immunological studies on the cell walls of Propionibacterium acnes strain C7 and Corynebacterium parvum ATCC 11829.
    Azuma I; Sugimura K; Taniyama T; Aladin A; Yamamura Y
    Jpn J Microbiol; 1975 Aug; 19(4):265-75. PubMed ID: 811835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Corynebacterium parvum on tumor growth in the central nervous system of mice.
    Conley FK; Remington JS
    J Natl Cancer Inst; 1978 Sep; 61(3):827-32. PubMed ID: 278860
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
    Woodruff MF; Dunbar N
    Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of the anti-metastatic activity of C. parvum by antilymphocyte serum.
    Sadler TE; Castro JE
    Br J Cancer; 1976 Sep; 34(3):291-5. PubMed ID: 1086096
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.
    Woodruff MF; Warner NL
    J Natl Cancer Inst; 1977 Jan; 58(1):111-6. PubMed ID: 299893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of functionally distinct subpopulations of Corynebacterium parvum-activated macrophages with predominantly stimulatory or suppressive effect on the cell-mediated cytotoxic T cell response.
    Lee KC; Kay J; Wong M
    Cell Immunol; 1979 Jan; 42(1):28-41. PubMed ID: 312146
    [No Abstract]   [Full Text] [Related]  

  • 16. Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen.
    Scott MT
    Cell Immunol; 1974 Aug; 13(2):251-63. PubMed ID: 4281350
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppressor T cells and suppressor macrophages induced by Corynebacterium parvum.
    Lichtenstein A; Murahata R; Sugasawara R; Zighelboim J
    Cell Immunol; 1981 Mar; 58(2):257-68. PubMed ID: 6452218
    [No Abstract]   [Full Text] [Related]  

  • 18. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
    Scott MT; Milas L
    Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological effects of the adjuvant Corynebacterium parvum. II. Evidence for macrophage-T-cell interaction.
    Scott MT
    Cell Immunol; 1972 Nov; 5(3):469-79. PubMed ID: 4405135
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
    Ghaffar A; Cullen RT
    J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.